Analysis finds rising BPC-157 use despite thin human evidence

The wire

1. 01A new U.S. analysis found BPC-157, marketed online as the "Wolverine" peptide, is being used for a wide range of ailments despite little human safety or efficacy data.
2. 02Clinicians and pharmacists are likely to field more patient questions about a product sold through gray-market channels rather than approved supply.
3. 03The report describes usage patterns, not outcomes; controlled human trials establishing safety and efficacy are still lacking.

From the source

Use of untested ‘Wolverine’ peptide on the rise, U.S. study finds

An experimental peptide backed by U.S. Health Secretary Robert F. Kennedy Jr. and marketed online for pain, healing and performance enhancement is being used for a wide range of ailments despite little safety and efficacy evidence from human studies, a new analysis found.